Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Rank in Stocks #38667
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Share Price
$0.04057595
Last synced: 2024-08-05
Market Cap
$863.62K
Change (1 day)
0.31%
Change (1 year)
0.00%
Country
SE
Trade AegirBio AB (publ) (AEGIR)

Category

Earnings for AegirBio AB (publ) (AEGIR)
Earnings in Sep 2024 TTM: $-3.81M
According to AegirBio AB (publ) latest financial reports the company's current earnings are $-3.81M. In 2022 the company made an earning of $-34.94M, a decrease compared to its 2021 earnings that were of $-10.24M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for AegirBio AB (publ) from 2019 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-3.81M -37.26%
2023 $-6.07M -82.64%
2022 $-34.94M 241.24%
2021 $-10.24M 36.29%
2020 $-7.51M 28,276,939.29%
2019 $-26.57 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$3.81B -100,104.94%
US
$4.11B -108,067.95%
FR
- -
JP
$1.59B -41,880.40%
US
- -
CH